Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 2, 2010, Pages 257-262

  Singh, Inder M ^a   Filby, Steven J ^a   El Sakr, Fredy ^a   Gorodeski, Eiran Z ^a   Lincoff, A Michael ^a   Ellis, Stephen G ^a   Shishehbor, Mehdi H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bare metal stents; Drug eluting stents; In stent restenosis; Revascularization; Vascular brachytherapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BARE METAL STENT; BRACHYTHERAPY; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; OHIO; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955154213     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22509     Document Type: Article

References (30)

1. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, et al.2007. Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008;51:172-209.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495. (Pubitemid 24256751)
4. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007;116:2391-2398. (Pubitemid 350145074)
5. Singh IM, Filby SJ, Sakr FE, Gorodeski EZ, Lincoff AM, Ellis SG, Shishehbor MH. Clinical outcomes of drug-eluting versus baremetal in-stent restenosis. Catheter Cardiovasc Interv 2010;75:338-342.
6. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006;151:1260-1264.
7. Schuhlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schomig A. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004;147:317-322. (Pubitemid 38176833)
8. Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drugeluting stent era. J Invasive Cardiol 2008;20:401-403.
9. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703. (Pubitemid 27251783)
10. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256. (Pubitemid 32108529)
11. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of instent restenosis: The INHIBIT randomised controlled trial. Lancet 2002;359:551-557. (Pubitemid 34178435)
12. Baierl V, Baumgartner S, Pollinger B, Leibig M, Rieber J, et al. Three-year clinical follow-up after strontium-90/yttrium-90 beta-irradiation for the treatment of in-stent coronary restenosis. Am J Cardiol 2005;96:1399-1403. (Pubitemid 41566621)
13. Costa MA, Sabate M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, Serrano P, Coen VL, Levendag PC, Serruys PW. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100:789-792. (Pubitemid 29398874)
14. vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: Results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002;105:583-588.
15. Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: Results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004;43:943-949.
16. Giri S, Ito S, Lansky AJ, Mehran R, Margolis J, et al. Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv 2001;52:24-34.
17. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003;42:796-805. (Pubitemid 37059735)
18. Alfonso F, Auge JM, Zueco J, Bethencourt A, Lopez-Minguez JR, et al. Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective stenting (RIBS) randomized study. J Am Coll Cardiol 2005;46:756-760. (Pubitemid 41224795)
19. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. (Pubitemid 37186209)
20. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231. (Pubitemid 38067635)
21. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, et al. Sirolimus-eluting stents vs. vascular brachytherapy for instent restenosis within bare-metal stents: The SISR randomized trial. JAMA 2006;295:1264-1273.
22. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, et al. Paclitaxel-eluting stents vs. vascular brachytherapy for instent restenosis within bare-metal stents: The TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
23. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: The TAXUS V ISR trial. Eur Heart J 2008;29:1625-1634. (Pubitemid 351958446)
24. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno MJ, Mehilli J, Schomig A. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: Meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:616-623. (Pubitemid 46177448)
25. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100: 1872-1878. (Pubitemid 29511140)
26. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol 2008;52:1621-1627.
27. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: Insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004;109:2727-2731. (Pubitemid 38737919)
28. Mehran R, Dangas G, Abizaid A, Lansky AJ, Mintz GS, et al. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. Am Heart J 2001;141:610-614. (Pubitemid 32260729)
29. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Fernandez C, Escaned J, et al. Sirolimus-eluting stents versus bare-metal stents in patients with in-stent restenosis: Results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv 2008;72:459-467.
30. Kim SW, Mintz GS, Escolar E, Ohlmann P, Pregowski J, et al. An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Am J Cardiol 2006;97:1292-1298.